Your browser doesn't support javascript.
loading
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
Yamaguchi, Motoko; Suzuki, Ritsuro; Kwong, Yok-Lam; Kim, Won Seog; Hasegawa, Yuichi; Izutsu, Koji; Suzumiya, Junji; Okamura, Takayuki; Nakamura, Shigeo; Kawa, Keisei; Oshimi, Kazuo.
Affiliation
  • Yamaguchi M; Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie 514-8507, Japan. waniwani@clin.medic.mie-u.ac.jp
Cancer Sci ; 99(5): 1016-20, 2008 May.
Article in En | MEDLINE | ID: mdl-18294294

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphoid / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Extranodal NK-T-Cell Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Year: 2008 Type: Article

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphoid / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Extranodal NK-T-Cell Type of study: Clinical_trials / Guideline / Prognostic_studies Limits: Adolescent / Adult / Aged / Humans / Middle aged Language: En Year: 2008 Type: Article